Circadian variation of sputum inflammatory cells in mild asthma

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 2, 2003, Pages 308-312

  Panzer, Sarah E ^a   Dodge, Ann M ^a   Kelly, Elizabeth A B ^a   Jarjour, Nizar N ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Circadian variations; Eosinophil; Induced sputum

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; INTERLEUKIN 5; NEUROTOXIN;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; ASTHMA; CELL ASSAY; CELL VIABILITY; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; HUMAN; HUMAN CELL; INFLAMMATION; INFLAMMATORY CELL; LEUKOCYTE; LUNG FUNCTION; LUNG FUNCTION TEST; PHLEBOTOMY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RESPIRATORY TRACT DISEASE; SPUTUM ANALYSIS;

EID: 0037323942     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.65     Document Type: Article

References (38)

1. Martin RJ, Banks-Schlegel S. Chronobiology of asthma. Am J Respir Crit Care Med 1998;158:1002-7.
2. Shamoo DA, Linn WS, Peng RC, Solomon JC, Webb TL, Hackney JD, et al. Time-activity patterns and diurnal variation of respiratory status in a panel of asthmatics: implications for short-term air pollution effects. J Expo Anal Environ Epidemiol 1994;4:133-48.
3. Lebowitz MD, Krzyzanowski M, Quackenboss JJ, O'Rourke MK. Diurnal variation of PEF and its use in epidemiological studies. Eur Respir J Suppl 1997;24:49S-56S.
4. Wijnhoven HA, Kriegsman DM, Hesselink AE, Penninx BW, de Haan M. Determinants of different dimensions of disease severity in asthma and COPD: pulmonary function and health-related quality of life. Chest 2001;119:1034-42.
5. Kraft M, Pak J, Martin RJ. Serum cortisol in asthma: marker of nocturnal worsening of symptoms and lung function? Chronobiol Int 1998;15:85-92.
6. Mackay TW, Wallace WA, Howie SE, Brwon PH, Greening AP, Church MK, et al. Role of inflammation in nocturnal asthma. Thorax 1994;49:257-62.
7. Martin RJ, Cicutto LC, Smith HR, Ballard RD, Szefler SJ. Airway inflammation in nocturnal asthma. Am Rev Respir Dis 1991;143:351-7.
8. Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin RJ. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996;154:1505-10.
9. Oosterhoff Y, Timens W, Postma DS. The role of airway inflammation in the pathophysiology of nocturnal asthma. Clin Exp Allergy 1995;25:915-21.
10. Oosterhoff Y, Kauffman HF, Rutgers B, Zijlstra FJ, Koeter GH, Postma DS. Inflammatory cell number and mediators in bronchoalveolar lavage fluid and peripheral blood in subjects with asthma with increased nocturnal airways narrowing. J Allergy Clin Immunol 1995;96:219-29.
11. Jarjour NN, Busse WW, Calhoun WJ. Enhanced production of oxygen radicals in nocturnal asthma. Am Rev Respir Dis 1992;146:905-11.
12. Jarjour NN, Busse WW. Cytokines in bronchoalveolar lavage fluid of patients with nocturnal asthma. Am J Respir Crit Care Med 1995;152:1474-7.
13. ten Hacken NHT, Timens W, Smith M, Drok G, Kraan J, Postma DS. Increased peak expiratory flow variation in asthma: severe persistent increase but not nocturnal worsening of airway inflammation. Eur Respir J 1998;12:546-50.
14. Kraft M, Martin RJ, Wilson S, Djukanovic R, Holgate S. Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma. Am J Respir Crit Care Med 1999;159:228-34.
15. Pin I, Freitag AP, O'Byrne PM, Girgis-Gabardo A, Watson RM, Dolovich J, et al. Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses. Am Rev Respir Dis 1992;145:1265-9.
16. Fahy JV, Kim KW, Liu J, Boushey HA. Respiratory pathophysiologic responses. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995;95:843-52.
17. Fahy JV, Liu J, Wong H, Boushey HA. Cellular and biochemical analysis of induced sputum from asthmatic and healthy subjects. Am Rev Respir Dis 1993;147:1126-31.
18. Liu LY, Swenson CA, Kita H, Kelly EAB, Busse WW. The relationship of airway eosinophilia and sputum cell generation of IL-5 following antigen challenge. J Allergy Clin Immunol 2000;106:1063-9.
19. Liu LY, Coe CL, Swenson CA, Kelly EA, Kita H, Busse WW. School examinations enhance airway inflammation to antigen challenge. Am J Respir Crit Care Med 2002;165:1062-7.
20. Olivenstein R, Taha R, Minshall EM, Hamid QA. IL-4 and IL-5 mRNA expression in induced sputum of asthmatic subjects: comparison with bronchial wash. J Allergy Clin Immunol 1999;103:238-45.
21. Keatings VM, O'Connor BJ, Wright LG, Huston DP, Corrigan CJ, Barnes PJ. Late response to allergen is associated with increased concentrations of tumor necrosis factor-α and IL-5 in induced sputum. J Allergy Clin Immunol 1997;99:693-8.
22. Sulakvelidze I, Inman MD, Rerecich T, O'Byrne PM. Increases in airway eosinophils and interleukin-5 with minimal bronchoconstriction during repeated low-dose allergen challenge in atopic asthmatics. Eur Respir J 1998;11:821-7.
23. Kelly EA, Rodriguez RR, Busse WW, Jarjour NN. The effect of segmental bronchoprovocation wilh allergen on airway lymphocyte function. Am J Respir Crit Care Med 1997;156:1421-8.
24. Abu-Ghazaleh RI, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ. IgA-induced eosinophil degranulation. J Immunol 1989;142:2393-400.
25. Glantz SA. Primer of bio-statistics. 4th ed. New York: McGraw-Hill Companies, Inc; 1997.
26. Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996;154:308-17.
27. Fahy JV, Boushey HA, Lazarus SC, Mauger EA, Cherniack RM, Chinchilli VM, et al. Safely and reproducibility of sputum induction in asthmatic subjects in a multicenter study. Am J Respir Crit Care Med 2001;163:1470-5.
28. Wilson NM, Bridge P, Spanevello A, Silverman M. Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity. Thorax 2000;55:768-74.
29. Thomas PS, Yates DH, Barnes PJ. Sputum induction as a method of analyzing pulmonary cells: reproducibility and acceptability. J Asthma 1999;36:335-41.
30. Spanevello A, Migliori GB, Sharara A, Ballardini L, Bridge P, Pisati P, et al. Induced sputum to assess airway inflammation: a study of reproducibility. Clin Exp Allergy 1997;27:1138-44.
31. in't Veen JC, de Gouw HW, Smits HH, Sont JK, Hiemstra PS, Sterk PJ, et al. Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma. Eur Respir J 1996;9:2441-7.
32. Martin RJ, Cicutto LC, Ballard RD. Factors related to the nocturnal worsening of asthma. Am Rev Respir Dis 1990:141:33-8.
33. 1 and peak expiratory flow rate in asthma. Am J Respir Crit Care Med 1995;152:1097-9.
34. Martin RJ. Small airway and alveolar tissue changes in nocturnal asthma. Am J Respir Crit Care Med 1998;157:S188-90.
35. Postma DS, Oosterhoff Y, van Aaldren WM, Kauffman HF, Wempe JB, Koëter GH. Inflammation in nocturnal asthma. Am J Respir Crit Care Med 1994;150:S83-6.
36. Kelly MM, Leigh R, Horsewood P, Gleich GJ, Cox G, Hargreave FE. Induced sputum: validity of fluid-phase IL-5 measurement. J Allergy Clin Immunol 2000;105:1162-8.
37. ten Hacken NHT, Oosterhoff Y, Kauffman HF, Guevarra L, Satoh T, Tollerud DJ, et al. Elevated serum interferon-γ in atopic asthma correlates with increased airways responsiveness and circadian peak expiratory flow variation. Eur Respir J 1998;11:312-6.
38. Calhoun WJ, Bates ME, Schrader L, Sedgwick JB, Busse WW. Characteristics of peripheral blood eosinophils in patients with nocturnal asthma. Am Rev Respir Dis 1992;145:577-81